BIOCRYST PHARMACEUTICALS INC
BIOCRYST PHARMACEUTICALS INC
Aktie · US09058V1035 · BCRX · 896047 (XNAS)
Übersicht Finanzkennzahlen
11,00 USD
0,92 % 0,10 USD
NASDAQ (XNAS) · Aktuelle Kurse und Charts bei MoneyPeak
06.06.2025 22:31

Aktuelle Kurse von BIOCRYST PHARMACEUTICALS INC

BörseTickerWährungLetzter UmsatzKursTagesveränderung
XNAS: NASDAQ
NASDAQ
BCRX
USD
06.06.2025 22:31
11,00 USD
10,98 USD
+0,18 %

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
0,00 % 3,19 % 7,11 % 39,95 % 44,55 % 70,81 % 163,79 %

Firmenprofil zu BIOCRYST PHARMACEUTICALS INC Aktie

BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase II clinical trial for complement-mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitor that is in Phase I clinical trial to treat fibrodysplasia ossificans progressiva; and Galidesivir, a RNA dependent-RNA polymerase inhibitor, which is in Phase I clinical trial to treat various RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; Mundipharma International Holdings Limited; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.

Investierte Fonds

Folgende Fonds haben in investiert: BIOCRYST PHARMACEUTICALS INC investiert:

Fonds
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in Mio
92,09
Anteil (%)
0,22 %

Unternehmensdaten

Name BIOCRYST PHARMACEUTICALS INC
Firma BioCryst Pharmaceuticals, Inc.
Symbol BCRX
Website https://www.biocryst.com
Heimatbörse XNAS NASDAQ
WKN 896047
ISIN US09058V1035
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Mr. Jon P. Stonehouse
Marktkapitalisierung 2 Mrd.
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,6 T
Adresse 4505 Emperor Boulevard, 27703 Durham
IPO Datum 1994-03-04

Ticker Symbole

Name Symbol
Frankfurt BO1.F
NASDAQ BCRX

Weitere Aktien

Investoren die BIOCRYST PHARMACEUTICALS INC die halten, haben auch folgende Aktien im Depot:
AMGEN INC
AMGEN INC Aktie
APPLE INC
APPLE INC Aktie
AUTODESK INC
AUTODESK INC Aktie
CISCO SYSTEMS INC
CISCO SYSTEMS INC Aktie
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Aktie
EL SALVADOR 02/23 REGS
EL SALVADOR 02/23 REGS Anleihe
INTEL CORP
INTEL CORP Aktie
MICROSOFT CORP
MICROSOFT CORP Aktie
OPAWICA EXPLOR.INC.
OPAWICA EXPLOR.INC. Aktie
PROCTER GAMBLE CORP
PROCTER GAMBLE CORP Aktie
ROBMKTS CL.A
ROBMKTS CL.A Aktie
TENCENT . LTD
TENCENT . LTD Aktie
TESLA INC
TESLA INC Aktie
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025